EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Endoscopic Characterization and Outcome of COVID-19 Patients with Secondary Sclerosing Cholangitis: A Case Series of a Tertiary Center

Pia Hofstetter, Ina Zuber-Jerger, Alexander Mehrl, Bernhard Graf, Dirk Lunz, Matthias Lubnow, Thomas Müller, Stephan Schmid, Martina Müller, Arne Kandulski

Journal of Gastrointestinal and Liver Diseases · 2024

DOI: 10.15403/jgld-5476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, 2024. Verfasst von Pia Hofstetter und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg…. Hauptthemen laut MEDLINE: COVID-19, Cholangitis, Sclerosing, Cholangiopancreatography, Endoscopic Retrograde, Tertiary Care Centers. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: During the coronavirus disease 2019 (COVID-19) pandemic a significant proportion of patients with severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection developed secondary sclerosing cholangitis (SSC) as a hepatobiliary complication.

Methods

17 patients were endoscopically diagnosed and treated with COVID-19 SSC from February 2020 until October 2022 at our center. We retrospectively reviewed and analyzed the data to define risk factors, establish endoscopic treatment options, and to estimate incidence and outcomes.

Results

258 patients with COVID-19 infection were admitted to our tertiary center and mechanically ventilated. 10 patients developed COVID-19 SSC in-house, and 7 patients were transferred for further endoscopic treatment. All 17 patients were mechanically ventilated, received vasoactive substances and 12 of them were treated with extracorporeal membrane oxygenation therapy. Endoscopic retrograde cholangiography (ERC) was performed in all patients to establish the diagnosis of COVID-19 SSC and evaluate endoscopic treatment options. All ERCs revealed biliary casts. 9 patients had developed severe rarefication of the intrahepatic bile ducts and 4 showed biliary strictures. As endoscopic treatment approaches, casts were removed repeatedly, and strictures were dilated. During the study period, 14 patients died (82%). 3 patients are in follow-up to reassess the need for liver transplantation.

Conclusions

COVID-19 SSC was observed in 2.6 % of the patients with severe COVID-19 in our center. We show that endoscopic approaches offer the opportunity to extract casts and to treat biliary strictures. As the mortality rate of COVID-19 SSC is high, endoscopic treatment can be of great clinical relevance as a bridge to liver transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cholangitis, SclerosingCholangiopancreatography, Endoscopic RetrogradeTertiary Care CentersHumansMaleFemaleMiddle AgedRetrospective StudiesAgedSARS-CoV-2AdultTreatment OutcomeRisk FactorsLiver Transplantation

Autor:innen und Institutionen

  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, Germany. . Pia.Goeggelmann@ukr.de.
  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg. ina.zuber-jerger@ukr.de.
  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg. alexander.mehrl@ukr.de.
  • Department of Anesthesiology, University Hospital Regensburg, Germany. bernhard.graf@ukr.de.
  • Department of Anesthesiology, University Hospital Regensburg, Germany. dirk.lunz@ukr.de.
  • Department of Internal Medicine II, Cardiology, Pneumology, and Intensive Care Medicine, University Hospital Regensburg, Germany. matthias.lubnow@ukr.de.

Zitieren

APA

Hofstetter, P., Zuber-Jerger, I., Mehrl, A., Graf, B., Lunz, D., Lubnow, M., Müller, T., Schmid, S., Müller, M., & Kandulski, A. (2024). Endoscopic Characterization and Outcome of COVID-19 Patients with Secondary Sclerosing Cholangitis: A Case Series of a Tertiary Center. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-5476

Vancouver

Hofstetter P, Zuber-Jerger I, Mehrl A, Graf B, Lunz D, Lubnow M, et al. Endoscopic Characterization and Outcome of COVID-19 Patients with Secondary Sclerosing Cholangitis: A Case Series of a Tertiary Center. Journal of Gastrointestinal and Liver Diseases. 2024. doi:10.15403/jgld-5476

BibTeX
@article{Hofstetter2024,
  author = {Hofstetter, Pia and Zuber-Jerger, Ina and Mehrl, Alexander and Graf, Bernhard and Lunz, Dirk and Lubnow, Matthias and Müller, Thomas and Schmid, Stephan and Müller, Martina and Kandulski, Arne},
  title = {Endoscopic Characterization and Outcome of COVID-19 Patients with Secondary Sclerosing Cholangitis: A Case Series of a Tertiary Center},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2024},
  doi = {10.15403/jgld-5476}
}
Kostenlos starten →